DRKS00026288招募中不适用
SARS-CoV-2-IgG-titer of antibodies in helathcare workers after recovery or vaccination
Evangelische Kliniken Gelsenkirchen0 个研究点目标入组 800 人开始时间: 2021年9月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Vaccination against SARS-CoV-2 or recovery after infection with SARS-CoV-2
排除标准
- •neither vaccinated nor recovered employees
研究者
相似试验
已完成
不适用
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers with differing risk of exposureCOVID-1910047438NL-OMON49447niversitair Medisch Centrum Groningen600
尚未招募
不适用
SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerSCoronavirus disease-19JPRN-UMIN000040694Kinki Health Administration Center, Mie Health Checkup Clinic1,000
进行中（未招募）
不适用
Prevalence of COVID19 antibodies among blood donors.CTRI/2021/01/030455ivetha M
进行中（未招募）
1 期
Immune response to SARS-CoV-2 in health care workers, previously infected subjects, and immunocompromised subjects, before and after Covid-19 vaccination: a phase IV trialEUCTR2021-001769-19-SEGUVAX (Gothenburg University Vaccine Research Institute)1,200
尚未招募
不适用
SARS CoV 2 antibody status of health care workers in a covid tertiary care hospital in Bangalore, Karnataka.CTRI/2021/03/031933Rajarajeswari medical college and hospital